Table 3.
Figures of subjects positive for inflammation biomarker between hypochlorous acid and placebo groups.
| Biomarker variation | HOCL (N = 27), negative positive | Placebo (N = 26), negative positive |
p value for HOCL vs. placebo Z-test |
||
|---|---|---|---|---|---|
| N (%) | n (%) | n (%) | n (%) | ||
| MMP-9 | |||||
| 1st day | 11 (40.74) | 16 (59.26) | 10 (38.46) | 16 (61.54) | |
| 55th day | 24 (88.88) | 3 (11.11) | 14 (53.84) | 12 (46.15) | Z = 0.896, ∗∗p = 0.002 |
| IL-2 | |||||
| 1st day | 12 (44.44) | 15 (55.55) | 11 (42.31) | 15 (57.69) | |
| 55th day | 25 (92.59) | 2 (7.41) | 16 (61.54) | 10 (38.46) | Z = 0.659, ∗∗p = 0.001 |
N: number of subjects in designated treatment; n: number of subjects in special category; %n (number of subjects in special category)/N (number of subjects in designated treatment) × 100; ∗p < 0.05 and∗∗p < 0.01.